160 related articles for article (PubMed ID: 30391152)
1. Corruption of neuroblastoma patient derived xenografts with human T cell lymphoma.
Williams AP; Stewart JE; Stafman LL; Aye JM; Mroczek-Musulman E; Ren C; Yoon K; Whelan K; Beierle EA
J Pediatr Surg; 2019 Oct; 54(10):2117-2119. PubMed ID: 30391152
[TBL] [Abstract][Full Text] [Related]
2. Complex genetic and histopathological study of 15 patient-derived xenografts of aggressive lymphomas.
Jakša R; Karolová J; Svatoň M; Kazantsev D; Grajciarová M; Pokorná E; Tonar Z; Klánová M; Winkowska L; Maláriková D; Vočková P; Forsterová K; Renešová N; Dolníková A; Nožičková K; Dundr P; Froňková E; Trněný M; Klener P
Lab Invest; 2022 Sep; 102(9):957-965. PubMed ID: 35488033
[TBL] [Abstract][Full Text] [Related]
3. Neuroblastoma patient-derived orthotopic xenografts retain metastatic patterns and geno- and phenotypes of patient tumours.
Braekeveldt N; Wigerup C; Gisselsson D; Mohlin S; Merselius M; Beckman S; Jonson T; Börjesson A; Backman T; Tadeo I; Berbegall AP; Ora I; Navarro S; Noguera R; Påhlman S; Bexell D
Int J Cancer; 2015 Mar; 136(5):E252-61. PubMed ID: 25220031
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the risk of lymphomagenesis in xenografts by the PCR-based detection of EBV BamHI W region in patient cancer specimens.
Mukohyama J; Iwakiri D; Zen Y; Mukohara T; Minami H; Kakeji Y; Shimono Y
Oncotarget; 2016 Aug; 7(31):50150-50160. PubMed ID: 27367028
[TBL] [Abstract][Full Text] [Related]
5. Prevention of Human Lymphoproliferative Tumor Formation in Ovarian Cancer Patient-Derived Xenografts.
Butler KA; Hou X; Becker MA; Zanfagnin V; Enderica-Gonzalez S; Visscher D; Kalli KR; Tienchaianada P; Haluska P; Weroha SJ
Neoplasia; 2017 Aug; 19(8):628-636. PubMed ID: 28658648
[TBL] [Abstract][Full Text] [Related]
6. Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.
Navone NM; van Weerden WM; Vessella RL; Williams ED; Wang Y; Isaacs JT; Nguyen HM; Culig Z; van der Pluijm G; Rentsch CA; Marques RB; de Ridder CMA; Bubendorf L; Thalmann GN; Brennen WN; Santer FR; Moser PL; Shepherd P; Efstathiou E; Xue H; Lin D; Buijs J; Bosse T; Collins A; Maitland N; Buzza M; Kouspou M; Achtman A; Taylor RA; Risbridger G; Corey E
Prostate; 2018 Dec; 78(16):1262-1282. PubMed ID: 30073676
[TBL] [Abstract][Full Text] [Related]
7. Ovarian carcinoma patient derived xenografts reproduce their tumor of origin and preserve an oligoclonal structure.
Colombo PE; du Manoir S; Orsett B; Bras-Gonçalves R; Lambros MB; MacKay A; Nguyen TT; Boissière F; Pourquier D; Bibeau F; Reis-Filho JS; Theillet C
Oncotarget; 2015 Sep; 6(29):28327-40. PubMed ID: 26334103
[TBL] [Abstract][Full Text] [Related]
8. Patient-derived xenografts as preclinical neuroblastoma models.
Braekeveldt N; Bexell D
Cell Tissue Res; 2018 May; 372(2):233-243. PubMed ID: 28924803
[TBL] [Abstract][Full Text] [Related]
9. Neuroblastoma patient-derived xenograft cells cultured in stem-cell promoting medium retain tumorigenic and metastatic capacities but differentiate in serum.
Persson CU; von Stedingk K; Bexell D; Merselius M; Braekeveldt N; Gisselsson D; Arsenian-Henriksson M; Påhlman S; Wigerup C
Sci Rep; 2017 Aug; 7(1):10274. PubMed ID: 28860499
[TBL] [Abstract][Full Text] [Related]
10. Early development of human lymphomas in a prostate cancer xenograft program using triple knock-out immunocompromised mice.
Wetterauer C; Vlajnic T; Schüler J; Gsponer JR; Thalmann GN; Cecchini M; Schneider J; Zellweger T; Pueschel H; Bachmann A; Ruiz C; Dirnhofer S; Bubendorf L; Rentsch CA
Prostate; 2015 May; 75(6):585-92. PubMed ID: 25585936
[TBL] [Abstract][Full Text] [Related]
11. Detection of Epstein-Barr virus nucleic acid sequences and protein in nodal T-cell lymphomas: relation between latent membrane protein-1 positivity and clinical course.
De Bruin PC; Jiwa NM; Van der Valk P; Van Heerde P; Gordijn R; Ossenkoppele GJ; Walboomers JM; Meijer CJ
Histopathology; 1993 Dec; 23(6):509-18. PubMed ID: 8314234
[TBL] [Abstract][Full Text] [Related]
12. [Transformation of patient-derived tumor xenografts into lymphomas: characteristics, influence factors and precautions].
Zou J; Gao J; Shen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jul; 19(7):833-7. PubMed ID: 27452762
[TBL] [Abstract][Full Text] [Related]
13. Characterization of patient-derived tumor xenografts (PDXs) as models for estrogen receptor positive (ER+HER2- and ER+HER2+) breast cancers.
Kanaya N; Somlo G; Wu J; Frankel P; Kai M; Liu X; Wu SV; Nguyen D; Chan N; Hsieh MY; Kirschenbaum M; Kruper L; Vito C; Badie B; Yim JH; Yuan Y; Hurria A; Peiguo C; Mortimer J; Chen S
J Steroid Biochem Mol Biol; 2017 Jun; 170():65-74. PubMed ID: 27154416
[TBL] [Abstract][Full Text] [Related]
14. Frequent presence of latent Epstein-Barr virus infection in lymphoepithelioid cell lymphoma (Lennert's lymphoma).
Anagnostopoulos I; Hummel M; Tiemann M; Korbjuhn P; Parwaresch MR; Stein H
Histopathology; 1994 Oct; 25(4):331-7. PubMed ID: 7835838
[TBL] [Abstract][Full Text] [Related]
15. Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts.
Corso S; Cargnelutti M; Durando S; Menegon S; Apicella M; Migliore C; Capeloa T; Ughetto S; Isella C; Medico E; Bertotti A; Sassi F; Sarotto I; Casorzo L; Pisacane A; Mangioni M; Sottile A; Degiuli M; Fumagalli U; Sgroi G; Molfino S; De Manzoni G; Rosati R; De Simone M; Marrelli D; Saragoni L; Rausei S; Pallabazzer G; Roviello F; Cassoni P; Sapino A; Bass A; Giordano S
Neoplasia; 2018 May; 20(5):443-455. PubMed ID: 29574251
[TBL] [Abstract][Full Text] [Related]
16. Lenvatinib inhibits the growth of gastric cancer patient-derived xenografts generated from a heterogeneous population.
Karalis JD; Yoon LY; Hammer STG; Hong C; Zhu M; Nassour I; Ju MR; Xiao S; Castro-Dubon EC; Agrawal D; Suarez J; Reznik SI; Mansour JC; Polanco PM; Yopp AC; Zeh HJ; Hwang TH; Zhu H; Porembka MR; Wang SC
J Transl Med; 2022 Mar; 20(1):116. PubMed ID: 35255940
[TBL] [Abstract][Full Text] [Related]
17. Anaplastic large cell lymphoma associated with Epstein-Barr virus following cardiac transplant.
Pitman SD; Rowsell EH; Cao JD; Huang Q; Wang J
Am J Surg Pathol; 2004 Mar; 28(3):410-5. PubMed ID: 15104308
[TBL] [Abstract][Full Text] [Related]
18. Patient-Derived Xenograft Models Reveal Intratumor Heterogeneity and Temporal Stability in Neuroblastoma.
Braekeveldt N; von Stedingk K; Fransson S; Martinez-Monleon A; Lindgren D; Axelson H; Levander F; Willforss J; Hansson K; Øra I; Backman T; Börjesson A; Beckman S; Esfandyari J; Berbegall AP; Noguera R; Karlsson J; Koster J; Martinsson T; Gisselsson D; Påhlman S; Bexell D
Cancer Res; 2018 Oct; 78(20):5958-5969. PubMed ID: 30154149
[TBL] [Abstract][Full Text] [Related]
19. Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors.
Wang D; Pham NA; Tong J; Sakashita S; Allo G; Kim L; Yanagawa N; Raghavan V; Wei Y; To C; Trinh QM; Starmans MH; Chan-Seng-Yue MA; Chadwick D; Li L; Zhu CQ; Liu N; Li M; Lee S; Ignatchenko V; Strumpf D; Taylor P; Moghal N; Liu G; Boutros PC; Kislinger T; Pintilie M; Jurisica I; Shepherd FA; McPherson JD; Muthuswamy L; Moran MF; Tsao MS
Int J Cancer; 2017 Feb; 140(3):662-673. PubMed ID: 27750381
[TBL] [Abstract][Full Text] [Related]
20. In situ localization of Epstein-Barr virus encoded RNA in non-nasal/nasopharyngeal CD56-positive and CD56-negative T-cell lymphomas.
Tsang WY; Chan JK; Yip TT; Ng CS; Wong KF; Poon YF; Ma VW
Hum Pathol; 1994 Aug; 25(8):758-65. PubMed ID: 7520016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
